CNRS Nantes University US2B US2B
home |  start a new run |  job status |  references&downloads |  examples |  help  

Should you encounter any unexpected behaviour,
please let us know.
 elNémo has been hacked on november 27th.
It has been moved away and runs again.
**Still some additional cleaning from time to time**
Sorry for the inconvenience.


***  IMMUNE SYSTEM 14-NOV-18 6N2U  ***

<R2> analysis for 2604131021151763097

---  normal mode 88  ---

This page gives a visualization of the normalized mean square displacement <R2> of all C-alpha atoms in the protein that are associated to this mode (black bars). The three components of the corresponding eigenvector are shown on the left (colored bars). Here is the raw data for <R2> and for the eigenvector (shift-click on the links for download).

XYZresidue<R2><R2>max = 0.0695
LYS 10.0024
GLU 20.0110
LEU 30.0122
ARG 40.0304
CYS 50.0175
GLN 60.0112
CYS 70.0151
ILE 80.0146
LYS 90.0368
THR 100.0079
TYR 110.0094
SER 120.0266
LYS 130.0466
PRO 140.0087
PHE 150.0117
HIS 160.0177
PRO 170.0176
LYS 180.0545
PHE 190.0505
ILE 200.0148
LYS 210.0133
GLU 220.0062
LEU 230.0139
ARG 240.0115
VAL 250.0161
ILE 260.0105
GLU 270.0172
SER 280.0085
GLY 290.0067
PRO 300.0126
HIS 310.0056
CYS 320.0080
ALA 330.0243
ASN 340.0115
THR 350.0070
GLU 360.0059
ILE 370.0124
ILE 380.0087
VAL 390.0074
LYS 400.0120
LEU 410.0133
SER 420.0217
ASP 430.0477
GLY 440.0549
ARG 450.0695
GLU 460.0326
LEU 470.0131
CYS 480.0067
LEU 490.0091
ASP 500.0089
PRO 510.0068
LYS 520.0080
GLU 530.0069
ASN 540.0136
TRP 550.0105
VAL 560.0097
GLN 570.0141
ARG 580.0060
VAL 590.0025
VAL 600.0077
GLU 610.0066
LYS 620.0055
PHE 630.0064
LEU 640.0127
LYS 650.0143
ARG 660.0151
ALA 670.0133
GLU 680.0117
ASN 690.0454

If you find results from this site helpful for your research, please cite one of our papers:

elNémo is maintained by Yves-Henri Sanejouand.
It was developed by Karsten Suhre.
Between 2003 and 2014, it was hosted by IGS (Marseille).
Between 2015 and 2025, it was hosted by US2B (Nantes).
Last modification: december 26th, 2025.